Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study-Reference-Cited by-同舟云学术

Therapeutic equivalence of vildagliptin 100 mg once daily modified release to 50 mg twice daily immediate release formulation: An open-label, randomized, two-period, single- and multiple-dose, 6-day crossover study

Published:2022-03 Issue:3 Volume:16 Page:102438
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Sangana Ramachandra^ORCID,Mittal Hemant^ORCID,Barsainya Sarita,Hoermann Aldo,Borde Parag,Naik Sachin,Thorat Anup Vilas,Zhang Jie,Valentin Marie-Anne,Kalluri Sampath

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference11 articles.

1. Diabetes mellitus type 2;Goyal,2021

2. Vildagliptin: a review of its use in type 2 diabetes mellitus;Keating;Drugs,2014

3. Efficacy and safety of vildagliptin in the management of type 2 diabetes mellitus;Iftekar;Ind J Pharma Pract,2012

4. Pill burden in patients with type 2 diabetes in Germany: subanalysis from the prospective, noninterventional PROVIL study;Blüher;Clin Diabetes,2015

5. Adhérence to therapies in patients with type 2 diabetes;García-Pérez;Diabetes Ther,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEVELOPMENT, CHARACTERIZATION AND PHARMACOKINETIC EVALUATION OF OPTIMIZED VILDAGLIPTIN SUSTAINED RELEASE MATRIX TABLET USING BOX-BEHNKEN DESIGN;International Journal of Applied Pharmaceutics;2024-01-07

2. Expert eValuation of Efficacy and Rationality of Vildagliptin “EVER-Vilda”: An Indian Perspective;Clinical Medicine Insights: Endocrinology and Diabetes;2024-01

3. A systematic review on the clinical pharmacokinetics of vildagliptin in healthy and disease populations;Expert Opinion on Drug Metabolism & Toxicology;2023-11-26

4. Pharmacokinetics and Food Effect Between a 100‐mg Sustained‐Release Tablet and a 50‐mg Immediate‐Release Tablet of Vildagliptin in Healthy Subjects;Clinical Pharmacology in Drug Development;2023-08-07

5. Development, validation and application of a liquid chromatography–tandem mass spectrometry method for the activity and inhibition of DPP-4;Bioanalysis;2022-03